William Blair Forecasts Addus HomeCare Q1 Earnings

Addus HomeCare Co. (NASDAQ:ADUS) – William Blair issued their Q1 2026 earnings estimates for shares of Addus HomeCare in a report issued on Monday, June 9th. William Blair analyst J. Haase forecasts that the company will earn $1.35 per share for the quarter. The consensus estimate for Addus HomeCare’s current full-year earnings is $4.59 per share. William Blair also issued estimates for Addus HomeCare’s Q2 2026 earnings at $1.46 EPS, Q3 2026 earnings at $1.53 EPS and Q4 2026 earnings at $1.80 EPS.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s revenue for the quarter was up 20.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.21 earnings per share.

Several other equities research analysts have also recently weighed in on the company. Stephens restated an “overweight” rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie restated an “outperform” rating and set a $133.00 price objective on shares of Addus HomeCare in a research report on Tuesday. Wall Street Zen downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Finally, JMP Securities reissued a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $142.57.

Addus HomeCare Stock Performance

ADUS opened at $114.03 on Wednesday. Addus HomeCare has a one year low of $88.96 and a one year high of $136.72. The company has a market cap of $2.10 billion, a P/E ratio of 26.09, a PEG ratio of 1.41 and a beta of 0.81. The business’s 50-day simple moving average is $107.15 and its 200-day simple moving average is $112.32.

Institutional Trading of Addus HomeCare

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Natixis grew its stake in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after purchasing an additional 132 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in shares of Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after purchasing an additional 214 shares during the period. BI Asset Management Fondsmaeglerselskab A S purchased a new position in Addus HomeCare in the 1st quarter valued at $41,000. Parkside Financial Bank & Trust increased its stake in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after buying an additional 148 shares during the period. Finally, Meeder Asset Management Inc. purchased a new position in Addus HomeCare during the 4th quarter worth $77,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm’s stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the transaction, the executive vice president now owns 7,796 shares of the company’s stock, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.